Amundi Asset Management US’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-273,614
| Closed | -$13.1K | – | 1625 |
|
|
2018
Q4 | $13.1K | Sell |
273,614
-195,576
| -42% | -$9.34K | 0.01% | 577 |
|
|
2018
Q3 | $23.6M | Buy |
469,190
+106,484
| +29% | +$5.35M | 0.03% | 497 |
|
|
2018
Q2 | $18.3M | Sell |
362,706
-25,919
| -7% | -$1.31M | 0.03% | 549 |
|
|
2018
Q1 | $19M | Sell |
388,625
-2,032
| -0.5% | -$99.2K | 0.03% | 499 |
|
|
2017
Q4 | $17.3M | Sell |
390,657
-104,683
| -21% | -$4.64M | 0.03% | 510 |
|
|
2017
Q3 | $25.1M | Sell |
495,340
-3,858
| -0.8% | -$196K | 0.08% | 193 |
|
|
2017
Q2 | $26.9M | Buy |
499,198
+65,978
| +15% | +$3.56M | 0.09% | 177 |
|
|
2017
Q1 | $22.8M | Sell |
433,220
-3,280
| -0.8% | -$173K | 0.08% | 192 |
|
|
2016
Q4 | $21M | Buy |
436,500
+2,880
| +0.7% | +$139K | 0.07% | 208 |
|
|
2016
Q3 | $23.4M | Sell |
433,620
-880
| -0.2% | -$47.4K | 0.08% | 202 |
|
|
2016
Q2 | $23.5M | Sell |
434,500
-6,716
| -2% | -$364K | 0.09% | 187 |
|
|
2016
Q1 | $22.4M | Hold |
441,216
| – | – | 0.08% | 192 |
|
|
2015
Q4 | $22.3M | Sell |
441,216
-24,481
| -5% | -$1.23M | 0.08% | 205 |
|
|
2015
Q3 | $22.4M | Sell |
465,697
-595,633
| -56% | -$28.6M | 0.09% | 207 |
|
|
2015
Q2 | $55.3M | Buy |
1,061,330
+94,194
| +10% | +$4.9M | 0.2% | 133 |
|
|
2015
Q1 | $55.8M | Buy |
967,136
+2,175
| +0.2% | +$125K | 0.2% | 128 |
|
|
2014
Q4 | $51.6M | Buy |
964,961
+699,555
| +264% | +$37.4M | 0.19% | 145 |
|
|
2014
Q3 | $15.3M | Buy |
265,406
+190,825
| +256% | +$11M | 0.06% | 290 |
|
|
2014
Q2 | $4.99M | Buy |
+74,581
| New | +$4.99M | 0.02% | 457 |
|